News

CAMBRIDGE, Mass.–(BUSINESS WIRE)–TILT Holdings Inc. (“TILT” or the “Company”) (CSE: TILT) (OTCMKTS: SVVTF), a vertically-integrated infrastructure and technology cannabis company, announced today the appointment of Dr. San Li as Senior Lab Director for its wholly-owned subsidiary Jupiter Research (“Jupiter”), a leading designer, developer and manufacturer of vaporizing technologies for natural plant-derived oil. Dr. Li has…

Tilray® Increases International Export Capacity With New Outdoor Cultivation Site in Portugal

NANAIMO, British Columbia–(BUSINESS WIRE)–Tilray, Inc. (“Tilray” or “the Company”) (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced that its wholly-owned subsidiary Tilray Portugal Unipessoal Lda. (“Tilray Portugal”) has signed a Definitive Agreement (“The Agreement) with Esporão, adding 20 hectares of outdoor cultivation space in Alentejo, Portugal, in addition to its…

Acerus Reports Second Quarter and Year to Date Fiscal 2019 Financial Results

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:ASP; OTCQB:ASPCF) today reported its financial results for the three and six-month period ended June 30, 2019. Unless otherwise noted, all amounts are in US dollars and are prepared in accordance with International Financial Reporting Standards (“IFRS”). Second Quarter Highlights Continued growth of NATESTO® in the Canadian…

Halo Announces the Launch of XES Sensual, a Unique CBD Sexual Wellness Product Continues Company Trend of Product Innovation in Growing Category

TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that it is launching XES Sensual, the first sexual wellness system with an integrated applicator, specifically designed to deliver a cannabidiol (“CBD”) formulation through vaginal application. XES Sensual is the first sexual wellness product that features both…

Columbia Care Reports Second Quarter 2019 Results

NEW YORK–(BUSINESS WIRE)–Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, today reported financial and operating results for its second quarter ended June 30, 2019. All financial information is provided…

Tenet Healthcare Foundation Makes $100,000 Contribution in Support of El Paso Community

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC), through The Tenet Healthcare Foundation, is making a $100,000 donation to the El Paso Community Foundation to provide support to victims and families in El Paso following the tragic events on August 3. With 5,300 team members in the community, Tenet operates four acute care hospitals under The Hospitals…

World Antiemetics Market Opportunities and Forecasts, 2017-2018 & 2019-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “World Antiemetics Market – Opportunities and Forecasts, 2017 – 2023” report has been added to ResearchAndMarkets.com’s offering. Antiemetics are therapeutic agents that are effective against nausea and vomiting. Nausea and vomiting are the symptoms of several medical conditions such as motion sickness, dizziness, pregnancy, emotional stress and food poisoning. These drugs are often…

Diamond CBD Continues Its Strong Sales Momentum at ASD Market Week, Las Vegas, Attended by Thousands of Buyers from Around the World

FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–As a result of its sales success at the March 2019 ASD Market Week Trade Show held in New Orleans, at which it booked over $300,000 in product sales, Diamond CBD, a wholly-owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN) (“the Company”), again showcased its expanded product line at ASD Market…

ZYUS Completes Acquisition of Revon Systems

SASKATOON, Saskatchewan–(BUSINESS WIRE)–ZYUS Life Sciences Inc. (“ZYUS”) announced today that it has completed the previously announced acquisition of Kentucky-based healthcare technology company Revon Systems, Inc. (“Revon”). ZYUS, which is focused on the global development and commercialization of innovative and patient-focused cannabinoid-based therapeutics and product candidates, intends to utilize Revon’s proprietary artificial intelligence–enabled technology platform as…

Cresco Labs to Report Second Quarter 2019 Financial Results on August 21, 2019

CHICAGO–(BUSINESS WIRE)–Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, will report its financial results for the second quarter ended June 30, 2019 on Wednesday, August 21, 2019 after the market closes. The Company will hold a conference call…

EMMAC Life Sciences Ltd: Research collaboration with University of Insubria

August 5, 2019

LONDON–(BUSINESS WIRE)–EMMAC (“EMMAC” or the “Company”) , the leading European independent medical cannabis company, is pleased to announce a collaboration with the Center of Research in Medical Pharmacology at the Italian University of Insubria, to deliver a long-term research programme on screening of Cannabinoids through an ex vivo/in vitro human immune cells-based platform. The programme…

Tenet Reports Results for the Second Quarter Ended June 30, 2019

August 5, 2019

DALLAS–(BUSINESS WIRE)–Tenet Healthcare Corporation (NYSE: THC) reported net income from continuing operations attributable to Tenet common shareholders of $15 million in the second quarter of 2019 compared to net income of $24 million in the second quarter of 2018. Adjusted EBITDA was $657 million in the second quarter of 2019 above the midpoint of the…